Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BPC-157 is supported by animal and in-vitro studies and reviews of its pharmacology
Magkos, F., & Mantzoros, C
BPC-157 & TB-500 CAPSULE SET: This research set combines BPC-157 (250mcg per capsule) and TB-500 (500mcg per capsule), two synthetic peptides studied for their roles in angiogenesis, actin regulation, tissue remodeling, and cellular signaling
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
US$ 29.35
US$ 28.84
US$ 26.23
US$ 24.59
US$ 22.66
